Is oncology Pharma efficiently growing its dividend?
Oncology Pharma does not have a long track record of dividend growth. In the past three months, Oncology Pharma insiders have not sold or bought any company stock. 18.00% of the stock of Oncology Pharma is held by insiders. A high percentage of insider ownership can be a sign of company health.
What is the ticker symbol for oncology Pharma?
Oncology Pharma trades on the OTCMKTS under the ticker symbol "ONPH." How do I buy shares of Oncology Pharma? Shares of ONPH can be purchased through any online brokerage account.
Where can I buy onph shares?
Shares of ONPH can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here.
How do I buy shares of Oncology Pharma?
How do I buy shares of Oncology Pharma? Shares of ONPH can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here.
Is Oncology Pharma a good buy?
The Oncology Pharma stock holds a buy signal from the short-term moving average; at the same time, however, the long-term average holds a general sell signal. Since the longterm average is above the short-term average there is a general sell signal in the stock giving a more negative forecast for the stock.
Is ONPH a strong buy?
Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good....Momentum Scorecard. More Info.Zacks RankDefinitionAnnualized Return1Strong Buy24.75%2Buy18.15%3Hold9.70%4Sell5.35%2 more rows
Does ONPH stock pay dividends?
Dividends. ONPH does not currently pay a dividend.
Is Oncology Pharma stock a buy?
If you are looking for stocks with good return, Oncology Pharma Inc stock can be a bad, high-risk 1-year investment option. Oncology Pharma Inc real time quote is equal to 1.390 USD at 2022-07-24, but your current investment may be devalued in the future.
What does Oncology Pharma do?
Oncology Pharma, Inc. is a pioneering oncology company dedicated to providing the financing and the tools to license, develop, manufacture, and commercialize therapeutics.
Is ONPH stock on Robinhood?
Shares of ONPH can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Is ONPH on Nasdaq?
*Today's High/Low is only updated during regular trading hours; and does not include trades occurring in pre-market or after-hours....ONPH Real-Time Quotes.Nasdaq Last Sale (NLS) Plus Volume39,995Today's High / Low*$1.53/$1.4152 Week High / LowN/A1 more row•Jul 8, 2022
What is the price of Oncology Pharma Incorporated?
Performance OutlookPrevious Close1.4660Day's Range1.4200 - 1.490052 Week Range1.3100 - 32.4700Volume14,665Avg. Volume57,5703 more rows
Does Oncology Pharma pay dividends?
Oncology Pharma (ONPH) does not pay a dividend.
What is the best stock to buy right now?
With that in mind, here are nine of the best stocks to look into this month:Amazon (NASDAQ: AMZN) Buy AMZN. ... Alphabet Inc. (NASDAQ: GOOG | GOOGL) ... Apple (NASDAQ: AAPL) Buy AAPL. ... Gevo (NASDAQ: GEVO) Buy GEVO. ... The Walt Disney Company (NYSE: DIS) ... Netflix (NASDAQ: NFLX) ... NVIDIA (NASDAQ: NVDA) ... Bio-Rad Laboratories (NYSE: BIO)
Is ONPH on Webull?
Webull offers kinds of Oncology Pharma Inc stock information, including OTCPK:ONPH real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ONPH stock news, and many more online research tools to help you make informed decisions.
Is ONPH a OTC stock?
ONPH | Oncology Pharma Inc. Stock Overview (U.S.: OTC) | Barron's.
Is ONPH on Webull?
Webull offers kinds of Oncology Pharma Inc stock information, including OTCPK:ONPH real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ONPH stock news, and many more online research tools to help you make informed decisions.
Short Interest ()
Per-Share Earnings, Actuals and Estimates
Money flow measures the relative buying and selling pressure on a stock, based on the value of trades made on an "uptick" in price and the value of trades made on a "downtick" in price. The up/down ratio is calculated by dividing the value of uptick trades by the value of downtick trades.
Outset Medical, Inc. (OM) Reports Q4 Loss, Tops Revenue Estimates
Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International stock quotes are delayed as per exchange requirements. Fundamental company data and analyst estimates provided by FactSet.
Outset Medical Reports Fourth Quarter and Full Year 2021 Financial Results
Outset Medical, Inc. (OM) delivered earnings and revenue surprises of -14.93% and 6.04%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
Oncology Pharma Expands on Feasibility Studies and Data
SAN JOSE, Calif., February 16, 2022--Outset Medical, Inc. (Nasdaq: OM) ("Outset" or the "Company"), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, today reported financial results for the fourth quarter and full year ended December 31, 2021.
Oncology Pharma, Inc. and Regen BioPharma, Inc. Announce Intent to Jointly Fast Track Development of Modified mRNA anti-Cancer Vaccine
SAN FRANCISCO, CA / ACCESSWIRE / February 17, 2022 / Oncology Pharma Inc. (OTC PINK:ONPH) - Oncology Pharma, Inc.
Oncology Pharma Gives Update on Technology, Formulation and Data Creation
SAN FRANCISCO, CA / ACCESSWIRE / February 14, 2022 / Oncology Pharma, Inc. ("The Company") (OTC PINK:ONPH) and Regen BioPharma, Inc.
Oncology Pharma's New Year Update
SAN FRANCISCO, CA / ACCESSWIRE / February 8, 2022 / Oncology Pharma Inc. (OTC PINK:ONPH) - Oncology Pharma, Inc.
Oncology Pharma Meeting Towards Future Developments
SAN FRANCISCO, CA / ACCESSWIRE / January 10, 2022 / Oncology Pharma Inc. (OTC PINK:ONPH) - Oncology Pharma, Inc.
Oncology Pharma Year End Review and Outlook
SAN FRANCISCO, CA / ACCESSWIRE / December 17, 2021 / Oncology Pharma Inc. (OTC PINK:ONPH) Oncology Pharma, Inc.
Oncology Pharma Research and Vision
SAN FRANCISCO, CA / ACCESSWIRE / December 9, 2021 / Oncology Pharma Inc. (OTC PINK:ONPH) - Oncology Pharma, Inc.
Omico Corporation
SAN FRANCISCO, CA / ACCESSWIRE / November 30, 2021 / Oncology Pharma Inc. (OTC PINK:ONPH) - Oncology Pharma, Inc.
Recent Disclosures
Labels : Omico Corporation, OM, historical stock quote, stock information, Price to Earning, P/E Ratio, Open, High, 52 Week High, 52 Week Low, Earnings Per Share, Number of Outstanding Shares, Current Share Price, Historical Data, PSE, Philippines, PH, RP
